AQP4 and neuromyelitis optica: Additionally, neuromyelitis optica spectrum disorder, characterized by central nervous system inflammation and demyelination, is mediated by anti-aquaporin-4 (anti-AQP4) auto-antibodies targeting astrocytes and subsequent complement activation (39).